These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 8832223

  • 1. Genomic responses to 5-HT1A or 5-HT2A/2C receptor activation is differentially regulated in four regions of rat brain.
    Tilakaratne N, Friedman E.
    Eur J Pharmacol; 1996 Jun 27; 307(2):211-7. PubMed ID: 8832223
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS, Assié MB, Koek W.
    J Pharmacol Exp Ther; 1997 Aug 27; 282(2):747-59. PubMed ID: 9262338
    [Abstract] [Full Text] [Related]

  • 3. N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline studies on the role of 5-HT1A and 5-HT2 receptors in mediating foot-shock-induced ultrasonic vocalisation in adult rats.
    Sánchez C, Mørk A.
    Eur Neuropsychopharmacol; 1999 Jun 27; 9(4):287-94. PubMed ID: 10422888
    [Abstract] [Full Text] [Related]

  • 4. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
    Schreiber R, Brocco M, Audinot V, Gobert A, Veiga S, Millan MJ.
    J Pharmacol Exp Ther; 1995 Apr 27; 273(1):101-12. PubMed ID: 7714755
    [Abstract] [Full Text] [Related]

  • 5. Differential effects of 5-HT agonists and antagonists on the repeated acquisition and performance of response sequences in monkeys.
    Winsauer PJ, Moerschbaecher JM.
    Behav Pharmacol; 2000 Nov 27; 11(7-8):535-53. PubMed ID: 11198126
    [Abstract] [Full Text] [Related]

  • 6. Effects of 5-HT1A, 5-HT2A and 5-HT2C receptor agonists and antagonists on responding for a conditioned reinforcer and its enhancement by methylphenidate.
    Fletcher PJ, Zeeb FD, Browne CJ, Higgins GA, Soko AD.
    Psychopharmacology (Berl); 2017 Mar 27; 234(5):889-902. PubMed ID: 28097374
    [Abstract] [Full Text] [Related]

  • 7. The 5-HT1A receptor full agonist, 8-OH-DPAT inhibits ACTH-induced 5-HT2A receptor hyperfunction in rats: involvement of 5-HT1A receptors in the DOI-induced wet-dog shakes in ACTH-treated rats.
    Kitamura Y, Kitagawa K, Fujitani Y, Shibata K, Araki H, Sendou T, Gomita Y.
    Biol Pharm Bull; 2007 Jan 27; 30(1):117-20. PubMed ID: 17202670
    [Abstract] [Full Text] [Related]

  • 8. Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT.
    Misane I, Ogren SO.
    Neuropsychopharmacology; 2000 Feb 27; 22(2):168-90. PubMed ID: 10649830
    [Abstract] [Full Text] [Related]

  • 9. Differential regulation of somatodendritic serotonin 5-HT1A receptors by 2-week treatments with the selective agonists alnespirone (S-20499) and 8-hydroxy-2-(Di-n-propylamino)tetralin: microdialysis and autoradiographic studies in rat brain.
    Casanovas JM, Vilaró MT, Mengod G, Artigas F.
    J Neurochem; 1999 Jan 27; 72(1):262-72. PubMed ID: 9886078
    [Abstract] [Full Text] [Related]

  • 10. Chronic treatment with fluoxetine decreases cerebral metabolic responses to the 5-HT1A agonist 8-hydroxy-2(di-N-propylamino)tetralin and increases those to the 5-HT2A/2C agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane and to the dopaminergic agonist apomorphine.
    Freo U, Merico A, Ermani M, Ori C.
    Brain Res; 2010 Jun 04; 1335():24-34. PubMed ID: 20381465
    [Abstract] [Full Text] [Related]

  • 11. Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats.
    Willins DL, Meltzer HY.
    J Pharmacol Exp Ther; 1997 Aug 04; 282(2):699-706. PubMed ID: 9262333
    [Abstract] [Full Text] [Related]

  • 12. Desensitization of 5-HT1A receptors by 5-HT2A receptors in neuroendocrine neurons in vivo.
    Zhang Y, Gray TS, D'Souza DN, Carrasco GA, Damjanoska KJ, Dudas B, Garcia F, Zainelli GM, Sullivan Hanley NR, Battaglia G, Muma NA, Van de Kar LD.
    J Pharmacol Exp Ther; 2004 Jul 04; 310(1):59-66. PubMed ID: 15064330
    [Abstract] [Full Text] [Related]

  • 13. Limited participation of 5-HT(1A) and 5-HT(2A/2C) receptors in the clozapine-induced Fos-protein expression in rat forebrain regions.
    Sebens JB, Kuipers SD, Koch T, Ter Horst GJ, Korf J.
    Eur J Pharmacol; 2000 Nov 10; 408(1):11-7. PubMed ID: 11070178
    [Abstract] [Full Text] [Related]

  • 14. Involvement of spinal serotonin receptors in the regulation of intraspinal acetylcholine release.
    Kommalage M, Höglund AU.
    Eur J Pharmacol; 2005 Feb 21; 509(2-3):127-34. PubMed ID: 15733547
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The effects of long-term treatment with the 5-HT1A receptor agonist 8-OH-DPAT and the 5-HT2/1C receptor agonist DOI in the neonatal rat.
    Johansson-Wallsten CE, Berg M, Meyerson BJ.
    Eur J Pharmacol; 1993 Oct 19; 243(2):149-54. PubMed ID: 8276064
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses.
    Trillat AC, Malagié I, Mathé-Allainmat M, Anmela MC, Jacquot C, Langlois M, Gardier AM.
    Eur J Pharmacol; 1998 Apr 17; 347(1):41-9. PubMed ID: 9650846
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.